Amiel Moshfegh, MD
Vascular & Interventional Radiology · Commerce, CANPI 1144539644
Payments from drug & device makers
What this record shows
This record is dominated by other: $194,417 of the $201,880 with a category attached, or 96.3%. Angiodynamics, Inc. accounts for 96.5% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $82,067, more than ten times the $1,865 reported in 2019. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $726.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$195K
- Abbott$4K
- Philips North America LLC$1K
- Medtronic$822
- Boston Scientific$223
- Veryan Medical Incorporated$166
- plus $349 from 6 others
What the payments were for
- Food & beverage$7,4634%
- Other$194,41796%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 21 | $194,812 |
| Abbott | 137 | $4,280 |
| Philips North America LLC | 48 | $1,228 |
| Medtronic(2 entities) | 54 | $822 |
| Boston Scientific | 6 | $223 |
| Veryan Medical Incorporated | 3 | $166 |
| Dova Pharmaceuticals | 1 | $123 |
| Bard Peripheral Vascular, Inc. | 2 | $87 |
| BD | 3 | $68 |
| VYNE Pharmaceuticals Inc. | 1 | $26 |
| Cardiovascular Systems Inc. | 1 | $24 |
| Nevro Corp. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$194,524
- Perclose ProGlide suture mediated closure system$633
- PERCLOSE PROGLIDE$229
- Supera peripheral stent system$210
- (6576) Laser serv and other$149
- BioMimics 3D Vascular Stent System$136
- Perclose ProStyle$128
- (4067) Tack Endo Sys BTK$126
- DOPTELET$123
How this compares
$201,880 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 12 | $14,095 |
| ClopidogrelClopidogrel Bisulfate | 86 | $799 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Commerce
- Mahmood RazaviOrange$2.4M
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Alexander MisonoNewport Beach$1.3M
- Kevin BurnsOrange$1.1M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Blaise BaxterSan Francisco$757K
- Navid EghbaliehLos Angeles$639K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.